Abstract
Disruption of the complex of BECN1 with BCL2 or BCL2L1/BCL-XL is an essential switch that turns on cellular autophagy in response to environmental stress or treatment with BH3 peptidomimetics. Recently, it has been proposed that BCL2 and BCL2L1/BCL-XL may inhibit autophagy indirectly through a mechanism dependent on the proapoptotic BCL2 family members, BAX and BAK1. Here we report that the BH3 mimetic, ABT-737, induces autophagy in parallel with disruption of BCL2-BECN1 binding in 2 different apoptosis-deficient cell types lacking BAX and BAK1, namely in mouse embryonic fibroblasts cells and in human colon cancer HCT116 cells. We conclude that the BH3 mimetic ABT- 737 induces autophagy through a BAX and BAK1-independent mechanism that likely involves disruption of BECN1 binding to antiapoptotic BCL2 family members.
Original language | English (US) |
---|---|
Pages (from-to) | 452-459 |
Number of pages | 8 |
Journal | Autophagy |
Volume | 11 |
Issue number | 3 |
DOIs | |
State | Published - Jan 1 2015 |
Keywords
- ABT-737
- Apoptosis
- Autophagy
- BAK1
- BAX
- BCL2
- BECN1 (Beclin 1)
ASJC Scopus subject areas
- Molecular Biology
- Cell Biology